Literature DB >> 15926926

Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts.

Andreas Toft Sørensen1, Lachlan Thompson, Deniz Kirik, Anders Björklund, Olle Lindvall, Merab Kokaia.   

Abstract

Intrastriatal grafts of fetal ventral mesencephalic tissue, rich in dopaminergic neurons, can reverse symptoms in Parkinson's disease. For development of effective cell replacement therapy, other sources of dopaminergic neurons, e.g. derived from stem cells, are needed. However, the electrophysiological properties grafted cells need to have in order to induce substantial functional recovery are poorly defined. It has not been possible to prospectively identify and record from dopaminergic neurons in fetal transplants. Here we used transgenic mice expressing green fluorescent protein under control of the rat tyrosine hydroxylase promoter for whole-cell patch-clamp recordings of endogenous and grafted dopaminergic neurons. We transplanted ventral mesencephalic tissue from E12.5 transgenic mice into striatum of neonatal rats with or without lesions of the nigrostriatal dopamine system. The transplanted cells exhibited intrinsic electrophysiological properties typical of substantia nigra dopaminergic neurons, i.e. broad action potentials, inward rectifying currents with characteristic 'sag', and spontaneous action potentials. The grafted dopaminergic neurons also received functional excitatory and inhibitory synaptic inputs from the host brain, as shown by the presence of both spontaneous and stimulation-evoked excitatory and inhibitory postsynaptic currents. Occurrence of spontaneous excitatory and inhibitory currents was lower, and of spontaneous action potentials was higher, in neurons placed in the dopamine-depleted striatum than of those in the intact striatum. Our findings define specific electrophysiological characteristics of transplanted fetal dopaminergic neurons, and we provide the first direct evidence of functional synaptic integration of these neurons into host neural circuitries.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15926926     DOI: 10.1111/j.1460-9568.2005.04116.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  13 in total

1.  Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells.

Authors:  Stina Friling; Elisabet Andersson; Lachlan H Thompson; Marie E Jönsson; Josephine B Hebsgaard; Evanthia Nanou; Zhanna Alekseenko; Ulrika Marklund; Susanna Kjellander; Nikolaos Volakakis; Outi Hovatta; Abdeljabbar El Manira; Anders Björklund; Thomas Perlmann; Johan Ericson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-21       Impact factor: 11.205

2.  Optogenetics enables functional analysis of human embryonic stem cell-derived grafts in a Parkinson's disease model.

Authors:  Julius A Steinbeck; Se Joon Choi; Ana Mrejeru; Yosif Ganat; Karl Deisseroth; David Sulzer; Eugene V Mosharov; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2015-01-12       Impact factor: 54.908

3.  Optogenetic Stimulation of Neural Grafts Enhances Neurotransmission and Downregulates the Inflammatory Response in Experimental Stroke Model.

Authors:  Marcel M Daadi; Jill Q Klausner; Bryce Bajar; Inbal Goshen; Christopher Lee-Messer; Soo Yeun Lee; Mårten C G Winge; Charu Ramakrishnan; Maisie Lo; Guohua Sun; Karl Deisseroth; Gary K Steinberg
Journal:  Cell Transplant       Date:  2015-06-30       Impact factor: 4.064

4.  Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice.

Authors:  Clare L Parish; Gonçalo Castelo-Branco; Nina Rawal; Jan Tonnesen; Andreas Toft Sorensen; Carmen Salto; Merab Kokaia; Olle Lindvall; Ernest Arenas
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

5.  Functional integration of grafted neural stem cell-derived dopaminergic neurons monitored by optogenetics in an in vitro Parkinson model.

Authors:  Jan Tønnesen; Clare L Parish; Andreas T Sørensen; Angelica Andersson; Cecilia Lundberg; Karl Deisseroth; Ernest Arenas; Olle Lindvall; Merab Kokaia
Journal:  PLoS One       Date:  2011-03-04       Impact factor: 3.240

6.  Monosynaptic Tracing using Modified Rabies Virus Reveals Early and Extensive Circuit Integration of Human Embryonic Stem Cell-Derived Neurons.

Authors:  Shane Grealish; Andreas Heuer; Tiago Cardoso; Agnete Kirkeby; Marie Jönsson; Jenny Johansson; Anders Björklund; Johan Jakobsson; Malin Parmar
Journal:  Stem Cell Reports       Date:  2015-05-21       Impact factor: 7.765

7.  Effects of Feeder Cells on Dopaminergic Differentiation of Human Embryonic Stem Cells.

Authors:  Zhenqiang Zhao; Yanlin Ma; Zhibin Chen; Qian Liu; Qi Li; Deyan Kong; Kunxiong Yuan; Lan Hu; Tan Wang; Xiaowu Chen; Yanan Peng; Weimin Jiang; Yanhong Yu; Xinfeng Liu
Journal:  Front Cell Neurosci       Date:  2016-12-20       Impact factor: 5.505

Review 8.  Historical perspective of cell transplantation in Parkinson's disease.

Authors:  Alejandra Boronat-García; Magdalena Guerra-Crespo; René Drucker-Colín
Journal:  World J Transplant       Date:  2017-06-24

9.  Cell therapy for Parkinson's disease: Why it doesn't work every time.

Authors:  Timothy J Collier; Caryl E Sortwell; Natosha M Mercado; Kathy Steece-Collier
Journal:  Mov Disord       Date:  2019-06-24       Impact factor: 10.338

10.  Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1.

Authors:  Kaneyasu Nishimura; Daisuke Doi; Bumpei Samata; Shigeo Murayama; Tsuyoshi Tahara; Hirotaka Onoe; Jun Takahashi
Journal:  Stem Cell Reports       Date:  2016-03-17       Impact factor: 7.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.